<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20211218053444N4</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-07-06</date_registration>
      <primary_sponsor>Kerman University of Medical Sciences</primary_sponsor>
      <public_title>Comparison of the Effect of high Versus low Pressure nCPAP on Extubation Success rate in Premature Infants</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of Extubation Failure Rates in Premature infants Receiving high Versus low Pressure nCPAP at Afzalipour Hospital in 2026: A Clinical Trial.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-07-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>199</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>https://irct.ir/trial/91278</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Randomization will be performed using block randomization with variable block sizes (4 or 6). The randomization sequence will be generated using statistical software and placed in sequentially numbered, sealed, opaque envelopes (SNOSE). The envelopes will remain concealed from the treating team and investigators until the infant is enrolled and prepared for extubation. Envelope opening and infant allocation will be performed by an individual independent of the treating team. This method was chosen due to the limited sample size (fewer than 100 participants per group) and the need to maintain balanced sample sizes between the two groups, Blinding description: Blinding will be performed for the outcome assessor and statistician. The outcome assessor (a neonatal subspecialist or trained nurse) and the statistician will be blinded to the intervention groups. The treating team and parents will not be blinded due to the nature of the intervention. Allocation concealment will be achieved using sequentially numbered, sealed, opaque envelopes (SNOSE).</study_design>
      <phase>3</phase>
      <hc_freetext>Extubation Failure in Premature Infants.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Receives high-pressure nCPAP (8–10 cmH₂O) immediately after extubation. Infants in this group receive surfactant (Beraksurf) via a feeding tube with PPV assistance over 2–3 minutes following intubation. After clinical readiness is confirmed, they are extubated and immediately placed on nCPAP at 8–10 cmH₂O. The primary outcome (extubation failure) is assessed for 7 days (168 hours). Intervention 2: Control group: Receives low/standard-pressure nCPAP (6–8 cmH₂O) immediately after extubation. Infants in this group, like the intervention group, receive surfactant (Beraksurf) via a feeding tube with PPV assistance over 2–3 minutes following intubation. After clinical readiness is confirmed, they are extubated and immediately placed on nCPAP at 6–8 cmH₂O (standard pressure). The primary outcome (extubation failure) is assessed for 7 days (168 hours).</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is Information will be shared, but how it will be published will be announced later</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Zahra Jamali</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Emam Blvd., Afazalipour Hospital</address>
        <city>کرمان</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7616913355</zip>
        <telephone>+98 34 3132 8000</telephone>
        <email>z.jamali@kmu.ac.ir</email>
        <affiliation>Kerman University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Zahra Jamali</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Emam Blvd., Afazalipour Hospital</address>
        <city>کرمان</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7616913355</zip>
        <telephone>+98 34 3132 8000</telephone>
        <email>z.jamali@kmu.ac.ir</email>
        <affiliation>Kerman University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Less than 37 Completed Weeks of Gestation (preterm infant)
Receiving Invasive Mechanical Ventilation (Via Endotracheal Tube) in the NICU
Being extubated for the first time (no History of previous extubation).
Obtaining written Informed Consent from Parents after full Explanation of the Procedures, Significance, and Outcomes of the study.</inclusion_criteria>
      <agemin>8 months</agemin>
      <agemax>8 months</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Parental Refusal
Congenital or Genetic anomalies Affecting Respiration
Lack of Ongoing Intensive Care Provision</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>P28.5</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Respiratory failure of newborn</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Receives high-pressure nCPAP (8–10 cmH₂O) immediately after extubation. Infants in this group receive surfactant (Beraksurf) via a feeding tube with PPV assistance over 2–3 minutes following intubation. After clinical readiness is confirmed, they are extubated and immediately placed on nCPAP at 8–10 cmH₂O. The primary outcome (extubation failure) is assessed for 7 days (168 hours).</i_keyword>
      <i_keyword>Control group: Receives low/standard-pressure nCPAP (6–8 cmH₂O) immediately after extubation. Infants in this group, like the intervention group, receive surfactant (Beraksurf) via a feeding tube with PPV assistance over 2–3 minutes following intubation. After clinical readiness is confirmed, they are extubated and immediately placed on nCPAP at 6–8 cmH₂O (standard pressure). The primary outcome (extubation failure) is assessed for 7 days (168 hours).</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Extubation Failure within 7 days post-Extubation, Defined as Impaired Oxygenation (FiO₂ ≥ 0.2 above Pre-extubation level), Respiratory Acidosis (pH &lt; 7.20 and PCO₂ &gt; 60 mmHg), Recurrent Apnea, or Urgent need for re-Intubation. Timepoint: Baseline Variables Measured before Extubation. Intervention Initiated immediately after Extubation (hour zero). Daily Assessment of Primary Outcome (Extubation failure) for 7 days (168 hours). Duration of Ventilation and Hospitalization Recorded throughout the study period. Mortality and Re-intubation Requirement recorded during Follow-up. Final data Analysis performed at the end of day 7. Method of measurement: Baseline Variables Measured before extubation. Intervention initiated immediately after extubation (hour zero). Daily Assessment of Primary Outcome (Extubation Failure) for 7 days (168 hours). Duration of Ventilation and Hospitalization Recorded throughout the study period. Mortality and re-intubation Requirement recorded during follow-up. Final data Analysis performed at the end of day 7.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Kerman University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-05-02</approval_date>
        <contact_name>Research Ethics Committees of Afzalipour Hospital- Kerman University of Medical Sciences</contact_name>
        <contact_address>Emam Blv., Hospital Afzalipour Kerman Kerman Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
